Efficacy of MabThera in patients with rheumatoid arthritis, by measurement of disease parameters through magnetic resonance of the hand (RESONAR Study).

Trial Profile

Efficacy of MabThera in patients with rheumatoid arthritis, by measurement of disease parameters through magnetic resonance of the hand (RESONAR Study).

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 23 May 2014

At a glance

  • Drugs Rituximab (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms RESONAR
  • Sponsors Roche
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 27 Mar 2014 According to ClinicalTrials.gov record, status changed from completed to discontinued.
    • 19 Nov 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top